Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Gamma-1-Schwerkettenkrankheit mit Immunvaskulitis und rheumatoider Arthritis

Gamma-1 heavy-chain disease with vasculitis and rheumatoid arthritis

  • 37 Accesses

  • 7 Citations

Summary

We are reporting about a case of gamma heavy-chain disease (Franklin's disease) with immunovasculitis and rheumatoid arthritis. The diagnosis was confirmed by the results of immunoelectrophoresis of the patient's serum and also by evidence of stimulated lymphocytes without light chain, but having gamma heavy-chain surface proteins.

The immunofixation of the serum showed two protein bands of gamma heavy-chains with different loads. These results are confirmed by a two dimensional electrophoresis and isoelectric focussing of the serum proteins. The pathologic protein consists of at least two different heavy-chain proteins (mol wt 40,000 and 80,000) with isoelectric points between pH 5.5 and 7.3. In the urine of the patient pathological gamma heavy chain-protein was found only in a very low concentration.

The predominant clinical symptom of the patient was a necrotizing vasculitis which became a therapeutical problem. In the immunofluorescence examination of the skin biopsy specimens, immunoglobulins and C3-complement could be detected in the stratum papillare. This fact would be compatible with the development of antibodies or immune complexes against deposited heavy-chain proteins. The arthropathy and the positive rheumatoid factor could similarly be explained by an immune complex mechanism.

This is a preview of subscription content, log in to check access.

Abbreviations

FITC:

Fluorescein-Isothiocyanate

Ig:

Immunglobulin

M.R.:

Patienteninitialen

Myel.:

Myelomserum

NS:

Normalserum

PWM:

Pokeweedemitogen

TRITC:

Tetramethylrhodamin-Isothiocyanate

Literatur

  1. 1.

    Abe M, Wakase U, Mori N, Kojima M (1983) Gamma heavy chain disease, Ultrastructural and immunohistochemical study. Acta Pathol Jpn 33/4:689–700

  2. 2.

    Blangarin P, Deviller P, Kindbeiter K, Madjar JJ (1984) Gamma heavy chain disease studie by two-dimensional electrophoresis and immuno-blotting techniques. Clin Chem 30/12:2021

  3. 3.

    Chiba K, Matsumoto J, Konno N, Oka T, Kasukawa R, Suzuki S (1982) Gamma chain disease associated with rheumathoid arthritis. (Author's transl) Ryumachi 22/2: 129–136

  4. 4.

    Cozzolino F, Vercelli D, Castigli E, Becucci A, di Guglielmo R (1982) A new case of gamma-heavy chain disease, Clinical and immunochemical studies. Scand J Jaematol 28/2, 145–150

  5. 5.

    Doe WF, Danon F, Seligmann M (1979) Immunodiagnosis of alpha chain disease. Clin Exp Immunol 36:189

  6. 6.

    Franklin EC, Lowenstein J, Bigelow B, Meltzer M (1964) Heavy chain disease-a new disorder of serum y-globulins: report of the first case. Am J Med 37:332–350

  7. 7.

    Kyle RA, Greipp PR, Banks PM (1981) The diverse picture of gamma heavy chain disease report of sevan cases and review of literature. Mayo Clin Proc 56/7:439–451

  8. 8.

    Lebreton JP, Fontaine M, Rousseaux J, Youinou P, Hurez D, Rivat-Peran L, Bernards JP (1982) Deleted IgG 1 an IgG 2H chains in a patient with an IgG subclass imbalance. Clin Exp Immunol 47/1:206–216

  9. 9.

    Lenders JW, Holdrinet RS, Nguven CH, De Waal R (1984) A case of gamma heavy chain monoclonal gammopathy of undetermined significance. Neth J Med (Netherlands) 27/10:412–416

  10. 10.

    Lyons RM, Chaplin H, Tillack TW, Majerus PW (1975) Gamma heavy chain disease: rapid, sustained response to cyclophosphamide and prednisone. Blood 46/1:1–9

  11. 11.

    Matsumoto H, Ito S, Miyazaki I, Ohta I (1983) Structural studies of a human gamma 3 myeloma protein (Jir) bearing the allotypic marker Gm (st). M Immunol 131/4:1865–1870

  12. 12.

    Mihaesco E, Guglielmi P, Brouet JC, Mihaesco C (1983) Biochemical and biosynthetic studies of a crystallizable human gamma 1 heavy chain disease protein. Scand J Immunol 18/2:145–152

  13. 13.

    Ockhuizen T, Smith JW, van Leeuwen M (1983) Rheumatoid arthritis associated with transient gamma 2-heavy chain disease. Rheumatol Int 3/4:167–172

  14. 14.

    Ockhuizen T, Jilderda JF, Cazemier T (1984) Sequential development of waldenstrom's macroglobulinemia and gamma 1 heavy chain disease in a single patient. Clinical. immunochemical, immunofluorescent and protein studies. Acta Haematol 71/1:53–59

  15. 15.

    Okuda K, Himeno Y, Ioyama I, Ohta M, Kitagawa M, Sugai S (1982) Gamma heavy chain disease and giant lymph node hyperplasia in a patient with impaired T call function. Jpn M Med 21/2:109–114

  16. 16.

    O'Conor GI Jr, Wyandt HE, Innes DJ, Normansell DE, Hess CE (1985) Gamma heavy chain disease report of a case associated with trisomy of chromosome 7. Cancer Genet Cytogenet 15/1–2:1–5

  17. 17.

    Osserman EF, Takatsuki K (1964) Clinical and immunochemical studies of four cases of heavy (Hy 2) chain disease. Am J Med 37:351–373

  18. 18.

    Pastuszak WT, Scholes JV, Kosciol C, Cartun R (1983) Gamma heavy chain disease where the heavy chains arise (letter). Am J Clin Pathol 79/4:520

  19. 19.

    Radl J (1970) Light chain typing of immunoglobulins in smail samples of biological materials. Immunology 19:137

  20. 20.

    Ritchie RF, Smith R (1976) Immunofixation: I. General principles and application to agarose gel electrophoresis. Clin Chem 22:497–499

  21. 20a.

    . Clin Chem 22:1935–1937

  22. 20b.

    . Clin Chem 22:1982–1985

  23. 21.

    Roda I, David MJ, Souche S, Coiffier B, Creyssel R (1985) Gamma 3 heavy chain disease and monoclonal IgMk in a patient with a gastrointestinal lymphoma. Haematologica (Pavia) 70/2:115

  24. 22.

    Santoro C, De Marchi M, van Loghem E, de Lange G, Malfi G, Vitelli A, Carbouara AD (1984) A new case of gamma heavy chain disease (LIA protein) with deletion of the hinge region. Ric Clin Lab 14/1:21–28

  25. 23.

    Scheidegger MJ (1955) Une microméthode de l'immunoéléctrophorése. Ing Arch Allergy 7:103

  26. 24.

    Seligmann M (1972) Heavy chain diseases. Rev Europ Edudes Clin Et Biol 12:349–355

  27. 25.

    Seligmann M, Mihaesco E, Preud'homme JL, Danon F, Brouet JC (1979) Heavy chain diseases: current findings and concepts. Immunol Rev 48:145–167

  28. 26.

    Silva-Moreno, Ruiz-Arguelles GJ, Lopez-Karpovitch X, Labardini-Mendez J (1983) Heavy chain disease report of four cases. Sangre (Barc) 28/1:89–98

  29. 27.

    Tracy RP, Currie RM, Kyle RA, Young DS (1982) Two-dimensional gel electrophoresis of serum specimens from patients with monoclonal gammopathies. Clinical Chemistry 28/4:900–907

  30. 28.

    Tracy RP, Kyle RA, Young DS (1984) Two-dimensional gel electrophoresis as an oid in the analysis of monoclonal gammopathies. Hum Pathol 15/2:122–129

  31. 29.

    Wester SM, Banks PM, Li CY (1982) The histopathology of gamma heavy chain disease. Am J Clin Pathol 78/4:427–436

  32. 30.

    Zawadzki A, Benedek TG, Ein D, Easton JM (1970) Rheumatoid arthritis terminating in heavy-chain disease. Annal Intern Med 70/2:335–347

  33. 31.

    Zikan J, Rozprimova L, Novotny J (1984) The gamma 1 heavy chain disease FOR protein is present in two molecular forms. Folia Microbiol 29/3:254–263

Download references

Author information

Additional information

Herrn Univ.-Prof. Dr. Braunsteiner gewidmet

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Stühlinger, W., Berek, K., Lapin, A. et al. Gamma-1-Schwerkettenkrankheit mit Immunvaskulitis und rheumatoider Arthritis. Klin Wochenschr 65, 359–368 (1987). https://doi.org/10.1007/BF01745573

Download citation

Key words

  • Heavy-chain diseases
  • Gamma heavy-chain disease
  • Rheumatoid arthritis
  • Immunovasculitis